Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.5 (
neuropathy target esterase
)
1,070
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rabbit myocardial cytosolic acyl coenzyme A (acyl-CoA) hydrolase activity was purified to near-homogeneity by ammonium sulfate precipitation and ion-exchange, gel filtration, chromatofocusing, and hydroxylapatite chromatographies. Kinetic analysis of the purified protein demonstrated a maximum velocity of 24 mumol/(mg . min) and an apparent Michaelis constant of 50 microM. Cytosolic acyl-CoA hydrolase and
lysophospholipase
activities cochromatographed in every fraction of every step. The purified protein was a single band (Mr 23 000) after sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver staining. These results suggest that cytosolic
lysophospholipase
and
palmitoyl-CoA hydrolase
activities are catalyzed by a single polypeptide with dual activities. Palmitoyl-CoA competitively inhibited
lysophospholipase
activity (Ki = 4 microM). Low concentrations (20 microM) of lysophosphatidylcholine or L-palmitoylcarnitine increased
palmitoyl-CoA hydrolase
activity at low palmitoyl-CoA concentrations but had little effect at high concentrations of palmitoyl-CoA. In contrast, high concentrations (100 microM) of lysophosphatidylcholine or L-palmitoylcarnitine inhibited
palmitoyl-CoA hydrolase
activity. The results suggest that interactions between endogenous cardiac amphiphiles and
palmitoyl-CoA hydrolase
contribute to the regulation of intracellular long-chain acyl-CoA concentrations and therefore potentially modulate fluxes of fatty acid through several biochemical pathways.
...
PMID:Purification of rabbit myocardial cytosolic acyl-CoA hydrolase, identity with lysophospholipase, and modulation of enzymic activity by endogenous cardiac amphiphiles. 614 28